Effect of Qianjin Huanglian pill on kidney in insulin resistance mice

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 7, 2009, Pages 889-892

  Tian, Aiping ^a   Zou, Chenhui ^a   Sun, Sujuan ^a   Chen, Yueteng ^a   Guo, Saishan ^a   Shen, Zhufang ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Insulin resistance; Kidney; Pathological conditions; Urinary albumin

Indexed keywords

ALBUMIN; GLUCOSE; GLUTAMATE SODIUM; HERBACEOUS AGENT; INSULIN; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HYPERPLASIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY; LOW DRUG DOSE; MEDICINAL PLANT; MOUSE; NONHUMAN; PILL; QIANJIN HUANGLIAN; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; INSULIN RESISTANCE; KIDNEY; KIDNEY GLOMERULUS; MALE; MICE; SODIUM GLUTAMATE;

EID: 67651218639     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chen X R, Chen Y T, Shen Z F. A competitive EUSA for ablumin in rat unrie[J]. J Immunoas Immunochem, 2004,25(1):81.
2. Zorad S, Macho L, Jezová D, et al. Partial characterization of insulin resistance in adipose tissueof monosodium glutamate-induced obese mice[J]. Ann N Y Acad Sci, 1997,827:541. (Pubitemid 27480298)
3. Oida K, Nakai T, Hayashi T, et al. Plasma lipoprotein of monosodium glutamate-induced obese mice[J]. Int J Obes, 1984,8(5):385. (Pubitemid 15215945)
4. Hirata A E, Andrade I S, Vaskevicius P, et al. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake[J]. Braz J Med Biol Res, 1997,30(5):671. (Pubitemid 127521185)
5. Kambham N, Markowitz G S, Valeri A M, et al. Obesity-related glomerulopathy: an emerging epidemic[J]. Kidney Int, 2001,59(4):1498.
6. Henegar J R, Bigler S A, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity[J]. J Am Soc Nephrol, 2001,12(6):1211. (Pubitemid 32472634)
7. Adelman R D. Obesity and renal disease[J]. Curr Opin Nephro Hyperten, 2002,11(3):331.
8. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity[J]. Am J Physiol Renal Physiol, 2000, 278(5):F817. (Pubitemid 30351084)
9. Dengel D R, Goldberg A P, Mayuga R S, et al. Insulin resistance, elevated glomerular filtration fraction, and renal injury[J]. Hypertension, 1996,28(1):127.
10. Reaven G M. The kidney: An unwilling accomphice in syndrome X[J]. Am J Kidney Dis, 1997,30(6):928.
11. Calles-Escandon J, Mirza S A, Sobel B E, et al. Induction of hyperinsulinemia combined with hyperglycema and hypertriglyceridemia increase plasminogen activator inhibitor 1 in blood in normal human subjects[J]. Diabetes, 1998,47(2):290. (Pubitemid 28079991)